[go: up one dir, main page]

EA201001002A1 - Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре - Google Patents

Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре

Info

Publication number
EA201001002A1
EA201001002A1 EA201001002A EA201001002A EA201001002A1 EA 201001002 A1 EA201001002 A1 EA 201001002A1 EA 201001002 A EA201001002 A EA 201001002A EA 201001002 A EA201001002 A EA 201001002A EA 201001002 A1 EA201001002 A1 EA 201001002A1
Authority
EA
Eurasian Patent Office
Prior art keywords
solid
growth hormones
microcapsules containing
containing growth
internal
Prior art date
Application number
EA201001002A
Other languages
English (en)
Inventor
Жоэль РИШАР
Хелен Габриелла Балдассини
Рита Агостинетто
Луиза Де-Анджелис
Франтс Дешамп
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA201001002A1 publication Critical patent/EA201001002A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение касается композиций гормона роста (GH), обладающих свойствами длительного высвобождения, в особенности человеческого гормона роста (hGH) и способов для их получения. Композиции гормона роста могут быть произведены без денатурации белка и могут легко вводиться пациенту, который в этом нуждается, с помощью обычного шприца через иглу, имеющую маленький диаметр.
EA201001002A 2007-12-21 2008-11-21 Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре EA201001002A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07024906 2007-12-21
PCT/EP2008/009849 WO2009080164A1 (en) 2007-12-21 2008-11-21 Solid lipid microcapsules containing growth hormone in the inner solid core

Publications (1)

Publication Number Publication Date
EA201001002A1 true EA201001002A1 (ru) 2011-06-30

Family

ID=40566364

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001002A EA201001002A1 (ru) 2007-12-21 2008-11-21 Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре

Country Status (15)

Country Link
US (1) US8729015B2 (ru)
EP (1) EP2231120B1 (ru)
JP (1) JP5773651B2 (ru)
KR (1) KR20100103846A (ru)
CN (1) CN101903014B (ru)
AR (1) AR069844A1 (ru)
AT (1) ATE514417T1 (ru)
AU (1) AU2008340785B8 (ru)
BR (1) BRPI0821359A2 (ru)
CA (1) CA2710062C (ru)
EA (1) EA201001002A1 (ru)
ES (1) ES2367093T3 (ru)
IL (1) IL206393A (ru)
WO (1) WO2009080164A1 (ru)
ZA (1) ZA201005167B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE514417T1 (de) 2007-12-21 2011-07-15 Merck Patent Gmbh Feststofflipid-mikrokapseln mit einem wachstumshormon im inneren festkern
WO2010017965A2 (en) * 2008-08-11 2010-02-18 Merck Serono S.A. SOLID LIPID MICROCAPSULES CONTAINING hGH
CN102370630B (zh) * 2010-08-11 2014-04-02 中国科学院过程工程研究所 重组人生长激素rhGH长效缓释微囊及其制备方法
IL277958B2 (en) 2011-11-18 2023-11-01 Regeneron Pharma Micro-particles of polymeric proteins
JP6554493B2 (ja) 2014-06-24 2019-07-31 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス
KR101602138B1 (ko) 2014-11-21 2016-03-10 강원대학교산학협력단 염화칼슘 미세입자가 봉입된 온도 의존성 고체지질입자 및 그 제조방법
US11103461B2 (en) * 2015-12-22 2021-08-31 The Trustees Of Princeton University Process for encapsulating soluble biologics, therapeutics, and imaging agents
KR20170079409A (ko) * 2015-12-30 2017-07-10 한미약품 주식회사 지속형 인간 성장 호르몬 결합체의 신규 액상 제제
CN109380730B (zh) * 2017-08-09 2023-02-03 内蒙古伊利实业集团股份有限公司 微胶囊油脂及其制备方法
WO2019055539A1 (en) 2017-09-12 2019-03-21 Prudhomme Robert K CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME
JP2021501753A (ja) 2017-11-03 2021-01-21 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ 徐放性ナノキャリア製剤を形成するための疎水性イオン対化およびフラッシュナノ沈殿
WO2020018890A1 (en) 2018-07-19 2020-01-23 Prudhomme Robert K Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents
US11731099B2 (en) 2018-07-20 2023-08-22 The Trustees Of Princeton University Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
US20200147032A1 (en) 2018-11-14 2020-05-14 Robert K. Prud'homme Dihydromyricetin hot melt extrusion formulations and methods for forming them
CN114240934B (zh) * 2022-02-21 2022-05-10 深圳大学 一种基于肢端肥大症的图像数据分析方法及系统
CN116571178B (zh) * 2023-05-11 2026-01-20 仲恺农业工程学院 一种蓝莓花色苷微胶囊的制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6068044A (ja) * 1983-09-24 1985-04-18 Tetsuo Kato 二重膜構造のマイクロカプセル
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
JPH04504122A (ja) * 1989-03-17 1992-07-23 ピットマン―ムーア・インコーポレイテッド 巨大分子タンパク質の制御放出考案物
CA2407154A1 (en) * 2000-04-27 2001-11-01 Verion, Inc Zero order release and temperature-controlled microcapsules and process for the preparation thereof
US6967028B2 (en) * 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
CA2516339A1 (en) * 2003-02-19 2004-09-02 Takeda Pharmaceutical Company Limited Dispersing agent for sustained-release preparation
KR20170042364A (ko) * 2006-06-05 2017-04-18 디에스엠 뉴트리셔널 프라덕츠 아게 개선된 쉘을 가지는 마이크로캡슐
ATE514417T1 (de) 2007-12-21 2011-07-15 Merck Patent Gmbh Feststofflipid-mikrokapseln mit einem wachstumshormon im inneren festkern

Also Published As

Publication number Publication date
BRPI0821359A2 (pt) 2015-06-16
KR20100103846A (ko) 2010-09-28
CN101903014A (zh) 2010-12-01
AU2008340785A1 (en) 2009-07-02
US20100310649A1 (en) 2010-12-09
AU2008340785B2 (en) 2014-05-08
EP2231120A1 (en) 2010-09-29
WO2009080164A1 (en) 2009-07-02
AU2008340785B8 (en) 2014-09-18
IL206393A (en) 2015-06-30
JP5773651B2 (ja) 2015-09-02
CA2710062C (en) 2016-05-31
ATE514417T1 (de) 2011-07-15
CN101903014B (zh) 2014-04-16
IL206393A0 (en) 2010-12-30
JP2011506499A (ja) 2011-03-03
US8729015B2 (en) 2014-05-20
ZA201005167B (en) 2011-03-30
ES2367093T3 (es) 2011-10-28
AR069844A1 (es) 2010-02-24
EP2231120B1 (en) 2011-06-29
CA2710062A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
EA201001002A1 (ru) Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре
PE20142332A1 (es) Metodo y formulacion para reducir la agregacion de una macromolecula bajo condiciones fisiologicas
WO2007117509A8 (en) High delivery rates for lipid based drug formulations, and methods of treatment thereof
EA200601761A1 (ru) Композиции в качестве адъювантов для усиления иммунных ответов на вакцины и способы их применения
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
NO20075136L (no) Nye liposompreparater
EA201300121A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
MY188825A (en) High-concentration monoclonal antibody formulations
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
MX2009001412A (es) Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas.
ATE494889T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
UA95488C2 (ru) Концентрированный раствор метотрексата для подкожного введения
EA201101706A1 (ru) Лекарственное средство на основе дииндолилметана(dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека
JP2013533268A5 (ru)
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
WO2008109119A3 (en) Wnt compositions and methods of use thereof
JP2016539921A5 (ru)
EA201101596A1 (ru) Композиция для непрерывной доставки лекарственного средства, содержащая геополимерное связующее
PL2043637T3 (pl) Sposoby i leki do podawania ibuprofenu
WO2009004995A1 (ja) 生理活性物質を定着および発現させる方法
EA201101565A1 (ru) Способы введения и составы для лечения регионарной жировой ткани
TW200833367A (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
ES2570774T3 (es) Uso de ácido araquidónico para reducir el riesgo de resistencia a la insulina más adelante en la vida